Page 104 - Journal of Special Operations Medicine - Summer 2015
P. 104

“Testing of Junctional Tourniquets by Military Medics

                             to Control Simulated Groin Hemorrhage”



                   Richard Schwartz, MD; Bradford Z. Reynolds, MD; Richard D. Gordon Jr, MD;
                        Stephen A. Shiver, MD; Matthew Lyon, MD; Steven B. Holsten, MD





               e read the article in the Fall 2014 issue titled   measurements were made in the common femoral artery
          W“Testing of Junctional Tourniquets by Military    (CFA). The device was placed in the abdominal region
                                                     1
          Medics to Control Simulated Groin Hemorrhage”  with   over the umbilicus; 100% of the volunteers were able to
          great interest. The study attempted to compare the suc-  tolerate application of the device, 100% showed reduc-
          cess rates of four junctional tourniquets in treating a   tion of flow, and 77% showed complete elimination of
          potential vascular injury at the level of the inguinal liga-  flow. 2
          ment. We believe that the study has a number of meth-
          odological problems that likely altered the conclusions   In a second study, published in  Military Medicine, we
          of the article.                                    used 16 British active duty Soldiers and also applied pulse
                                                             wave Doppler in the CFA.  The device was also placed
                                                                                    3
          One major problem is that the protocol described in the   in the abdominal region over the umbilicus. Again, in
          Methods section appears to have  not been followed.   this study, the device was tolerated by 100% of the study
          The protocol indicates that the inguinal area was stud-  participants. The device eliminated flow in the CFA in
          ied. It states that “the right groin was assessed first; the   93.75% of the subjects. In the current article, only two
                                                                                 3
          left groin was assessed second. Unilateral groin hemor-  subjects (11%) tolerated application of the device. Prior
          rhage was simulated. Each tester used each of the four   evidence from two separate investigators demonstrated
          models of tourniquet two times (once on the left and   that the device was tolerated in 100% of 25 subjects.
          once on the right side of the groin).” This is true for   The authors of the current article did not cite either of
          three of the devices; however, the Abdominal Aortic and   these previously published articles. The cause of this dis-
                             ™
          Junctional Tourniquet  (AAJT) was not studied in the   crepancy is unclear. It is unlikely that the pain tolerance
          inguinal area but rather in the abdominal or umbili-  of this group of Soldiers differs from that of emergency
          cal area. It is unclear why the authors did not test all   medicine physicians or British soldiers.
          four devices in the groin area according to their written
          protocol. The AAJT has always had US Food and Drug   One potential confounder is that in both previous stud-
          Administration (FDA) approval for inguinal (groin) ap-  ies the subjects had a single application of the device. In
          plication. Despite this, the investigators chose to apply   the current article, the subjects had the various devices
          the AAJT in its abdominal aortic placement rather than   placed eight times (three times on the right, three times
          in the groin placement. This is simply not a reasonable   on the left, and twice over the umbilicus) over a 3-hour
          comparison. It is well established that placement of the   time frame. The repetitive application of the device may
          AAJT in the abdominal configuration causes more dis-  cause anxiety or a bias with subsequent applications.
                                         2
          comfort than does groin placement.  The authors state   However, the discomfort of the device is far less than
          that the AAJT was not FDA approved for groin place-  what would be expected from a wound such as trau-
          ment at the time of the study; however, a review of FDA   matic bilateral amputations from a blast injury that
          filings shows the AAJT’s initial approval was for both   would require the use of an abdominal tourniquet.
          abdominal and inguinal application.
                                                             Despite the discomfort associated with the abdominal
          The validity of this study also comes into question be-  placement, the AAJT is the only device that appears to
          cause its findings are dramatically different than those   be capable of safely stopping all hemorrhage distal to
                                                                                4,5
          of two published studies looking at the abdominal place-  the aortic bifurcation.  This becomes very important
                                               ™
          ment of the Abdominal Aortic Tourniquet  (AAT). We   when one looks at the injury patterns of potential sur-
          previously published data based on use in nine healthy   vivors on the battlefield. Prospectively collected data
          emergency medicine physicians. Pulse wave Doppler   on UK military personnel in Afghanistan identified 32


                                                          94
   99   100   101   102   103   104   105   106   107   108   109